Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Cochin Shipyard among 5 F&O stocks with a sharp rise in futures open interest
Futures open interest in the NSE F&O segment rose sharply on June 11, with five stocks recording over 5% growth. Cochin Shipyard led the list, followed by Max Healthcare, Amber Enterprises, Nuvama Wealth, and Manappuram Finance, indicating fresh position build-up and heightened trading activity in select counters.
Zydus Lifesciences shares soar 7% to fresh record high after Q4 results. Should you buy, sell or hold?
Zydus Lifesciences shares climbed to a new 52-week high. The company reported a 9% rise in net profit and over 16% revenue growth for the January-March quarter. A Rs 1,100 crore share buyback was announced. Analysts from Nomura, Nuvama, Motilal Oswal, and JM Financial shared their views on the company's performance and future prospects.
Cipla shares rally 8% despite 55% YoY slump in Q4 profit. Why Citi, Nuvama, other brokerages hiked target
Cipla shares surged on Thursday, extending gains to nearly 11% in two sessions, after several brokerages turned bullish on the stock despite a weak Q4 performance. The stock hit an intraday high of Rs 1,432.10 as investors focused on future growth prospects over near-term earnings pressure.
Enduring wealth, lasting wellness. People in India are living longer. Are they also living well?
India's rising life expectancy faces a longevity paradox, with increased years not always translating to good health, compounded by rising medical inflation and low insurance penetration. Standard Chartered is bridging this gap by integrating health and wealth management through partnerships with Niva Bupa and WHOOP, focusing on proactive wellness and curated experiences for affluent clients.
Nuvama sees 37% upside in this healthcare stock. Should you buy?
Park Medi World is set to benefit from India's hospital bed shortage and growth in Tier II markets. Nuvama initiated coverage with a 'Buy' rating and a target price of ₹280, projecting a 37% upside. The company aims to expand bed capacity significantly by FY28.
Nuvama Share Price In Focus As Healthcare Sector Expansion Gains Attention | Stock Market Today - Samco
Nuvama Share Price In Focus As Healthcare Sector Expansion Gains Attention | Stock Market TodaySamco
Nuvama sees up to 39% upside in this healthcare stock; check details
According to the report, the company is expected to turn net debt-free by FY26.
Momentum Stocks: Vikran Engg, Deccan Cements, TSF Investments, gain up to 8% on sheer momentum
Dr Reddy's Labs, Nuvama Wealth, GMR Airports, Aurobindo Pharma, Apollo Hospitals, among others hit 52-week high.